⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT September 1, 2026

Lamotrigin 1A Pharma 50 mg - lösliche Tabletten (Tablette zur Herstellung einer Suspension zum Einnehmen)

📷 Wikipedia: Lamotrigine · Source
Lamotrigin 1A Pharma 50 mg - lösliche Tabletten (Tablette zur Herstellung einer Suspension zum Einnehmen)
📷 Wikipedia: Lamotrigine · Source
Lamotrigine 1A Pharma 50 mg - soluble tablets (tablets for oral suspension) Shortage of active ingredient. Affected packs: 30-tablet box, blister pack [unavailable since September 2026].
⚠️
Shortage ongoing
LAMOTRIGIN is currently in short supply in AT.
📈 Timeline
9 days active so far
September 2, 2026 September 10, 2026

What is this? Lamotrigin 1A Pharma 50 mg is a medicine that comes as a dissolvable tablet. It is used to treat seizures and mood disorders.

What's happening? The medicine is currently in short supply. The affected packs are not available since September 2026.

Does this affect me? If you take this medicine in Austria, you may be affected by the shortage.

What should I do? Talk to your pharmacist or doctor before making any changes to your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: N03AX09 · Reason: Verknappung des Wirkstoffes · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-01]

First published
September 1, 2026
Last refreshed by us
14 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Lamotrigin 1A Pharma 50 mg - lösliche Tabletten (Tablette zur Herstellung einer Suspension zum Einnehmen). Lamotrigine 1A Pharma 50 mg - soluble tablets (tablets for oral suspension) Shortage of active ingredient. Affected packs: 30-tablet box, blister pack [unavailable since September 2026].
When was this alert issued?
This alert was issued on September 1, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.